LONDON: Regulators would possibly approve totally different coronavirus vaccines candidates at totally different instances however that isn’t an issue, the chief trial investigator for the shot developed at Oxford College stated on Wednesday.
“I might not think about that both builders can submit for approval in all regulatory authorities on the identical time, or that every one regulatory authorities will take the identical time for approval,” Oxford’s Andrew Pollard instructed lawmakers.
“I believe it’s probably that we’ll have some regulatory approvals taking place earlier than others. And I don’t see that as an issue.”
Disclaimer: This put up has been auto-published from an company feed with none modifications to the textual content and has not been reviewed by an editor